Xiaoxiao Ma

Assistant Professor

The University of Alabama at Birmingham School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Xiaoxiao Ma is an Assistant Professor at the University of Alabama at Birmingham Medicine, USA. Her research focuses on immunotherapy, tumor ecosystems, and the mechanisms underlying cancer immunity, as evidenced by her recent articles on neoantigen immunogenicity and the impacts of specific mutations on antitumor responses. Additionally, she explores the role of cancer signaling pathways and their implications for treatment strategies.

Articles (10)

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Josef Leibold

Assistant Professor

Eberhard Karls Universität Tübingen

GERMANY

View details

Phillip Rappold

Assistant Professor

University of Rochester

UNITED STATES

View details

Dmitriy Zamarin

Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Di Yang

University of Texas Southwestern Medical Center

UNITED STATES

View details

Nicholas H Chakiryan

Assistant Professor

Knight Cancer Institute, Oregon Health and Science University

UNITED STATES

View details

Zhipeng Meng

Assistant Professor

University of Miami Miller School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Xiaoxiao Ma

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab

Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

The Hippo pathway mediates Semaphorin signaling

Solving the puzzle of what makes immunotherapies work.

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear Cell Renal Cell Carcinoma.

Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cells.

Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells.

Improved prediction of immune checkpoint blockade efficacy across multiple cancer types.

Qa-1<sup>b</sup> Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing.

Collaborators (6)

Josef Leibold

Phillip Rappold

Dmitriy Zamarin

Di Yang

Nicholas H Chakiryan

Zhipeng Meng

Make your next move.